These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2942395)

  • 21. Gonadectomy influences the inhibitory effect of the endogenous opiate system on pulsatile gonadotropin secretion.
    Masotto C; Negro-Vilar A
    Endocrinology; 1988 Aug; 123(2):747-52. PubMed ID: 2840268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endorphins: "opiates for the masses".
    Grossman A
    Med Sci Sports Exerc; 1985 Feb; 17(1):101-5. PubMed ID: 2984513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous opiates participate in the regulation of pulsatile luteinizing hormone release in an unopposed estrogen milieu: studies in estrogen-replaced, gonadectomized patients with testicular feminization.
    Veldhuis JD; Rogol AD; Perez-Palacios G; Stumpf P; Kitchin JD; Dufau ML
    J Clin Endocrinol Metab; 1985 Oct; 61(4):790-3. PubMed ID: 4031019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
    Sauder SE; Frager M; Case GD; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of naloxone on pulsatile luteinizing hormone in experimental hyperprolactinemia.
    Lafuente A; Marco J; Moreno ML; Esquifino AI
    Vet Hum Toxicol; 1994 Dec; 36(6):529-32. PubMed ID: 7900272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous opioid peptides and hypothalamo-pituitary function.
    Howlett TA; Rees LH
    Annu Rev Physiol; 1986; 48():527-36. PubMed ID: 3010826
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of endogenous opiates in LH secretion during the menstrual cycle.
    Quigley ME; Yen SS
    J Clin Endocrinol Metab; 1980 Jul; 51(1):179-81. PubMed ID: 7380991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous opioid peptides modulate the effect of corticotropin-releasing factor on gonadotropin release in the primate.
    Gindoff PR; Ferin M
    Endocrinology; 1987 Sep; 121(3):837-42. PubMed ID: 3113919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous opioid peptides and the control of gonadotrophin secretion.
    Brooks AN; Lamming GE; Haynes NB
    Res Vet Sci; 1986 Nov; 41(3):285-99. PubMed ID: 3544108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Regulation of gonadotropin fluctuation by beta-endorphin].
    Schurz B
    Gynakol Rundsch; 1987; 27 Suppl 1():29-37. PubMed ID: 2956171
    [No Abstract]   [Full Text] [Related]  

  • 31. Interaction of alpha-melanocyte-stimulating hormone with beta-endorphin to influence anterior pituitary hormone secretion in the female rat.
    Khorram O; McCann SM
    Endocrinology; 1986 Sep; 119(3):1071-5. PubMed ID: 2942393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoglycemia-induced inhibition of luteinizing hormone secretion in the rhesus monkey is not mediated by endogenous opioid peptides.
    Heisler LE; Pallotta CM; Reid RL; Van Vugt DA
    J Clin Endocrinol Metab; 1993 May; 76(5):1280-5. PubMed ID: 8388404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central nervous system peptide and amino acid modulation of luteinizing hormone and prolactin secretion in the pig.
    Kraeling RR; Barb CR; Leshin LS; Rampacek GB
    J Physiol Pharmacol; 1992 Dec; 43(4 Suppl 1):79-103. PubMed ID: 1343978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of beta-endorphin-induced blockade of ovulation and luteinizing hormone surge with prostaglandin E2.
    Leadem CA; Kalra SP
    Endocrinology; 1985 Aug; 117(2):684-9. PubMed ID: 3160573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A decline in endogenous opioid influence during the steroid-induced hypersecretion of luteinizing hormone in the rat.
    Gabriel SM; Berglund LA; Simpkins JW
    Endocrinology; 1986 Feb; 118(2):558-61. PubMed ID: 3510853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for an increased opioid inhibition of luteinizing hormone secretion in hyperprolactinemic patients with pituitary microadenoma.
    Quigley ME; Sheehan KL; Casper RF; Yen SS
    J Clin Endocrinol Metab; 1980 Mar; 50(3):427-30. PubMed ID: 7358828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of estrogen and progestin on endogenous opioid activity in oophorectomized women.
    Shoupe D; Montz FJ; Lobo RA
    J Clin Endocrinol Metab; 1985 Jan; 60(1):178-83. PubMed ID: 2981084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of endogenous opioid peptides in the initiation of the midcycle luteinizing hormone surge in normal cycling women.
    Rossmanith WG; Mortola JF; Yen SS
    J Clin Endocrinol Metab; 1988 Oct; 67(4):695-700. PubMed ID: 3138276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impairment of the opioidergic control of luteinizing hormone secretion in Turner's syndrome: lack of effect of gonadal steroid therapy.
    Petraglia F; Larizza D; Maghnie M; Facchinetti F; Volpe A; Bernasconi S; Genazzani AR; Severi F
    J Clin Endocrinol Metab; 1988 May; 66(5):1024-8. PubMed ID: 3129445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diurnal patterns of pulsatile luteinizing hormone secretion in hypothalamic amenorrhea: reproducibility and responses to opiate blockade and an alpha 2-adrenergic agonist.
    Khoury SA; Reame NE; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1987 Apr; 64(4):755-62. PubMed ID: 2880864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.